Australia, May 17 -- Celgene Corp., owns the trademark (2488537) for 'i-ACCESS' till Oct. 8, 2034.
Status: registered:
Registered/protected
Class: 44 [Programs in the nature of providing medical counseling and online medical information in the field of pharmaceuticals and safety issues pertaining to pharmaceuticals, and providing online medical information in the aforementioned fields by distributing written materials in connection therewith; programs in the nature of providing medical counseling and online medical information in the field of thalidomide and lenalidomide and safety issues pertaining to thalidomide and lenalidomide, and providing online medical information in the aforementioned fields by distributing written materials in connection therewith.]
Type of Mark: Word
Date of Acceptance: Nov. 25, 2024
Registration Advertised: May 16
For further details contact Spruson & Ferguson.
The original document can be viewed at: https://search.ipaustralia.gov.au/trademarks/search/view/2488537.
Disclaimer: Curated by HT Syndication.
